Telomir Pharmaceuticals Announces Publication Of Preclinical Zebrafish Data Showing Telomir-Zn Improved Visual Function And Retinal Structure In Age-Related Macular Degeneration Model; Says Clinical Focus Remains Oncology
Share
Why It Matters
Telomir shared lab results showing their medicine helped eyesight in fish studies. The company is still focused on cancer treatment, not eye disease.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.